Human Bone Graft in Epiphysiodesis
NCT04067895 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2022-08-24
Summary
This observational study is to document the application of human bone graft in the surgical treatment (epiphysiodesis) of leg length discrepancy or primordial gigantism and its subsequent healing process.
Conditions
- Leg Length Differences
- Primordial Gigantism
Interventions
- PROCEDURE
-
epiphysiodesis
All patients undergo surgical treatment of leg lengths discrepancies or primordial gigantism. Human bone graft screws will be used to stop the distraction of the growth plate.
Sponsors & Collaborators
-
Surgebright Gmbh
collaborator INDUSTRY -
Medical University of Vienna
lead OTHER
Eligibility
- Min Age
- 10 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-08-06
- Primary Completion
- 2023-09-30
- Completion
- 2024-09-30
Countries
- Austria
Study Locations
More Related Trials
-
Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy
NCT00174187 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Growth Hormone on Bone Metabolism in Anorexia Nervosa
NCT00283595 ·Status: COMPLETED ·Phase: PHASE2
-
Descriptive Study of Recombinant Human Insulin-Like Growth Factor for Osteoporosis in Werner's Syndrome
NCT00004815 ·Status: COMPLETED ·Phase: NA
-
Long-term Safety and Effectiveness of Growth Hormone With GHD, TS, CRF, SGA , ISS and PWS in Children
NCT01604395 ·Status: RECRUITING
-
Prevention of Growth Retardation by Early Treatment With Growth Hormone (GH) in Children With CJA Treated by Corticosteroid Therapy
NCT00174291 ·Status: TERMINATED ·Phase: PHASE3
-
Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years
NCT01066052 ·Status: COMPLETED ·Phase: PHASE4
-
Special Use-results Surveillance on Long Term Use of Sogroya® in Children With Short Stature Due to Growth Hormone Deficiency Where Epiphysial Discs Are Not Closed
NCT06109935 ·Status: ENROLLING_BY_INVITATION
-
A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury
NCT00638053 ·Status: TERMINATED ·Phase: PHASE4
-
Somatropin Therapy In Children Born Preterm But Appropriate For Gestational Age
NCT00174460 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of GH on Body Proportions and Final Height in X-Linked Hypophosphatemic Rickets
NCT00473187 ·Status: UNKNOWN ·Phase: PHASE1
-
Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in Patients With Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
NCT03972345 ·Status: ENROLLING_BY_INVITATION
-
The Effect of Local Injectet GH on the Collagen Synthesis in the Ligamentum Patella
NCT01158612 ·Status: COMPLETED ·Phase: NA
-
Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia.
NCT03794609 ·Status: TERMINATED
-
Treatment Of Short Stature With Genotropin In Children Born Small For Gestational Age Until Final Height
NCT00174421 ·Status: COMPLETED ·Phase: PHASE3
-
Genotropin Treatment in Short Prepubertal Children With Intra-Uterine Growth Retardation
NCT01073605 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Short Stature Children Due to Chronic Kidney Disease Before Transplantation
NCT03535415 ·Status: UNKNOWN ·Phase: PHASE3
-
Registry for Patients With Achondroplasia / Hypochondroplasia (OMPR-Ach/Hy)
NCT05328050 ·Status: RECRUITING
-
Study of Skeletal Disorders and Short Stature
NCT00001754 ·Status: COMPLETED
-
Effects of rhIGF-1 on Bone Metabolism in Adolescent Girls With Anorexia Nervosa
NCT00720122 ·Status: COMPLETED ·Phase: PHASE2
-
Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)
NCT01052623 ·Status: UNKNOWN ·Phase: PHASE4
-
Boost Brittle Bones Before Birth
NCT03706482 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
NCT00182091 ·Status: COMPLETED ·Phase: NA
-
The Dosage Exploration Study of PEG-rhGH for Treating Short Stature in Prepubertal and Pubertal Children
NCT06768411 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen®, on a Population of Children With Hypochondroplasia, Treated at Least 3 Years or Until Near Final Height, When Applicable, in Comparison With a Historic Cohort of Non-treated Children
NCT01111019 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23, a Known Phosphaturic Agent
NCT00334945 ·Status: COMPLETED